<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03733509</url>
  </required_header>
  <id_info>
    <org_study_id>180620002</org_study_id>
    <nct_id>NCT03733509</nct_id>
  </id_info>
  <brief_title>Intraoperative Direct vs Postoperative Ultrasound Guided Adductor Canal Nerve Block After Total Knee Arthroplasty</brief_title>
  <official_title>Intraoperative Direct Adductor Canal Nerve Block Versus Post Operative Ultrasound Guided Adductor Canal Nerve Block in Total Knee Arthroplasty: a Double-blind Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares analgesic effect between two techniques of adductor canal nerve block
      after total knee arthroplasty. The first group of the patients will receive intraoperative
      adductor canal nerve block; and the other group post operative ultrasound guided adductor
      canal nerve block. Investigators will measure postoperative opioid consumption, pain
      management and rehabilitation goals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total knee arthroplasty (TKA) is a successful alternative to treat late stage knee
      osteoarthritis (OA). Pain management has been one of the main focuses of postoperative care.
      Most surgeons prefer a comprehensive multimodal approach including preoperative
      pharmacological treatment, intraoperative infiltration with complex drug mixes and
      postoperative peripheral nerve block.

      The most common postoperative nerve block alternative is the proximal femoral nerve block
      (FNB) which has shown improvements on postoperative pain measured by reduced opioid
      consumption and decreased pain at rest. Its main detractors argue that the motor nerve block
      effect is deleterious to early ambulation and have promoted adductor canal nerve blocks
      (ACB). Described by Lund et al in 2011, ACB block main femoral pain sensory contributors to
      the knee (articular branches of obturator nerve, vastus medialis branch and saphenous nerve)
      but is more distal to most motor branches to the quadriceps allowing near to normal
      quadriceps strength.

      Standard ACB block is performed under ultrasound guidance after surgery completion, still in
      the operating room (OR). Recent literature has shown the anatomic feasibility of
      intraoperative ACB via blunt suprapatellar dissection in standard medial parapatellar TKA
      approaches. The study seeks to determine the effectiveness of standard ultrasound guidance
      ACB compared with intraoperative ACB.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 12, 2018</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two arm, randomly assigned</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Total blind (patient, physicians, outcome assessors and statistician) Closed envelope by independent randomizer is given to physician assistant. The assistant prepares randomly allocated placebo or local anesthetic. Group is coded so that statistician is also blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>24 hour opioid consumption</measure>
    <time_frame>First 24 hours after surgery</time_frame>
    <description>Opioid consumption by patient controlled analgesia (PCA) and any other oral or IV analgesics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>24 patient reported pain</measure>
    <time_frame>First 24 hours after surgery</time_frame>
    <description>Patient reported pain scale using visual analog scale (VAS) every 6 hours after surgery (0 hours, 6 hours, 12 hours, 18 hours and 24 hours)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time up and go Test</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Standardised test to determine patients ability to walk 24 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Discharge</measure>
    <time_frame>7 days</time_frame>
    <description>Time between surgery and patient in conditions for discharge: no IV requirements, basic walking capability and VAS pain score equal or below 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Active and passive knee range of motion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>Intraoperative Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Before skin closure, blunt suprapatellar dissection proximal to medial femoral condyle towards adductor canal. Nerve block at this level with 20ml of Bupivacaine 0.25%.
Postoperatively, mid-thigh ultrasound guided standard adductor canal nerve block with 20ml of saline solution (NaCl 0.9%).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Before skin closure, blunt suprapatellar dissection proximal to medial femoral condyle towards adductor canal. Nerve block at this level with 20ml of of saline solution (NaCl 0.9%).
Postoperatively, mid-thigh ultrasound guided standard adductor canal nerve block with 20ml Bupivacaine 0.25%.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraoperative Block</intervention_name>
    <description>One shot adductor canal nerve block with 20ml of bupivacaine 0.25% through surgical incision</description>
    <arm_group_label>Intraoperative Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound Block</intervention_name>
    <description>One shot adductor canal nerve block with 20ml of bupivacaine 0.25% mid-thigh</description>
    <arm_group_label>Ultrasound Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraoperative Placebo</intervention_name>
    <description>One shot adductor canal nerve infusion with 20ml of saline solution through surgical incision</description>
    <arm_group_label>Ultrasound Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound Placebo</intervention_name>
    <description>One shot adductor canal nerve infusion with 20ml of saline solution mid-thigh</description>
    <arm_group_label>Intraoperative Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary total knee arthroplasty

          -  Unilateral

          -  American Society of Anesthesiologists (ASA) score I, II or III

          -  Accepts spinal anesthesia

        Exclusion Criteria:

          -  General anesthesia

          -  Chronic kidney disease

          -  Drug or alcohol abuse

          -  Chronic opioid use

          -  Allergic to bupivacaine or similar
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pablo Besa</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pontificia Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pablo Besa, MD</last_name>
    <phone>(+569) 71399611</phone>
    <email>pablobesa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fernando Altermatt, MD</last_name>
    <phone>(+562) 2686 3270</phone>
    <email>falterma@med.puc.cl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pontificia Universidad Católica de Chile</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <zip>8330024</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alejandro Soza, MD</last_name>
      <phone>56-2-23543820</phone>
      <phone_ext>3820</phone_ext>
      <email>asoza@med.puc.cl</email>
    </contact>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>November 6, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2018</study_first_posted>
  <last_update_submitted>March 16, 2020</last_update_submitted>
  <last_update_submitted_qc>March 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

